Drug: ranibizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 133 Number of Pages: 7
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| Ranibizumab | Myocardial infarction | 1 | view events |
| Ranibizumab | Nausea | 1 | view events |
| Ranibizumab | Neoplasm malignant | 1 | view events |
| Ranibizumab | Nervous system disorder | 1 | view events |
| Ranibizumab | Off label use | 1 | view events |
| Ranibizumab | Polymyalgia rheumatica | 1 | view events |
| Ranibizumab | Pseudoendophthalmitis | 1 | view events |
| Ranibizumab | Retinopathy | 1 | view events |
| Ranibizumab | Subarachnoid haemorrhage | 1 | view events |
| Ranibizumab | Venous thrombosis | 1 | view events |
| Ranibizumab | Vomiting | 1 | view events |
| RANIBIZUMAB 0.3 MG GENENTECH | Cardiac disorder | 1 | view events |
| RANIBIZUMAB 0.3 MG GENENTECH | Oedema peripheral | 1 | view events |
Total Drug/Injury Combinations: 133 Number of Pages: 7
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)